ATE267203T1 - Wasserfreie salze - Google Patents

Wasserfreie salze

Info

Publication number: ATE267203T1
Authority: AT; Austria
Prior art keywords: pyridin; anhydrous salts; anhydrous; ylsulphonyl; ethylpiperazin
Prior art date: 1999-10-11

Application number

AT00962772T

Other languages

English (en)

Inventor

Michael Leslie Hughes

Richard Anthony Storey

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-11

Filing date

2000-10-06

Publication date

2004-06-15

2000-10-06 Application filed by Pfizer filed Critical Pfizer

2004-06-15 Application granted granted Critical

2004-06-15 Publication of ATE267203T1 publication Critical patent/ATE267203T1/de

Links

150000003839 salts Chemical class 0.000 title 1
QDPNAMRLQRQPMR-UHFFFAOYSA-N 3-ethyl-5-[5-(4-ethylpiperazin-1-yl)sulfonyl-2-(2-methoxyethoxy)pyridin-3-yl]-2-(pyridin-2-ylmethyl)-4h-pyrazolo[4,3-d]pyrimidin-7-one Chemical class C1CN(CC)CCN1S(=O)(=O)C1=CN=C(OCCOC)C(C=2NC(=O)C3=NN(CC=4N=CC=CC=4)C(CC)=C3N=2)=C1 QDPNAMRLQRQPMR-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Otolaryngology (AREA)
Gynecology & Obstetrics (AREA)
Ophthalmology & Optometry (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Separation Of Suspended Particles By Flocculating Agents (AREA)

AT00962772T 1999-10-11 2000-10-06 Wasserfreie salze ATE267203T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9923968.3A GB9923968D0 (en)	1999-10-11	1999-10-11	Therapeutic agents
PCT/IB2000/001445 WO2001027101A2 (en)	1999-10-11	2000-10-06	Anhydrous salt

Publications (1)

Publication Number	Publication Date
ATE267203T1 true ATE267203T1 (de)	2004-06-15

Family

ID=10862471

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00962772T ATE267203T1 (de)	1999-10-11	2000-10-06	Wasserfreie salze

Country Status (17)

Country	Link
EP (1)	EP1220855B1 (de)
JP (1)	JP2003511446A (de)
AT (1)	ATE267203T1 (de)
AU (1)	AU7441100A (de)
BR (1)	BR0014656A (de)
CA (1)	CA2382937A1 (de)
CO (1)	CO5271692A1 (de)
DE (1)	DE60010914T2 (de)
DK (1)	DK1220855T3 (de)
ES (1)	ES2219395T3 (de)
GB (1)	GB9923968D0 (de)
PA (1)	PA8503701A1 (de)
PE (1)	PE20010674A1 (de)
PT (1)	PT1220855E (de)
SV (1)	SV2002000191A (de)
TN (1)	TNSN00196A1 (de)
WO (1)	WO2001027101A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002089808A1 (de) *	2001-05-09	2002-11-14	Bayer Healthcare Ag	Neue verwendung von 2-phenyl-substituierten imidazotriazinonen
GB0126417D0 (en) *	2001-11-02	2002-01-02	Pfizer Ltd	Crystal structure
DE10232113A1 (de)	2002-07-16	2004-01-29	Bayer Ag	Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
BRPI0409931A (pt) *	2003-05-01	2006-04-25	Pfizer	cristal de pde5, sua estrutura de cristal e seu em projeto de droga

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6723719B1 (en) *	1997-04-25	2004-04-20	Pfizer Inc	Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction
RS50011B (sr) *	1998-04-20	2008-09-29	Pfizer Inc.,	Derivati piridin-3-karboksilne kiseline i njihova upotreba kao intermedijera

1999
- 1999-10-11 GB GBGB9923968.3A patent/GB9923968D0/en not_active Ceased
2000
- 2000-09-27 PA PA20008503701A patent/PA8503701A1/es unknown
- 2000-10-05 PE PE2000001054A patent/PE20010674A1/es not_active Application Discontinuation
- 2000-10-06 CA CA002382937A patent/CA2382937A1/en not_active Abandoned
- 2000-10-06 EP EP00962772A patent/EP1220855B1/de not_active Expired - Lifetime
- 2000-10-06 PT PT00962772T patent/PT1220855E/pt unknown
- 2000-10-06 AT AT00962772T patent/ATE267203T1/de not_active IP Right Cessation
- 2000-10-06 DK DK00962772T patent/DK1220855T3/da active
- 2000-10-06 AU AU74411/00A patent/AU7441100A/en not_active Abandoned
- 2000-10-06 ES ES00962772T patent/ES2219395T3/es not_active Expired - Lifetime
- 2000-10-06 JP JP2001530319A patent/JP2003511446A/ja active Pending
- 2000-10-06 WO PCT/IB2000/001445 patent/WO2001027101A2/en not_active Ceased
- 2000-10-06 BR BR0014656-0A patent/BR0014656A/pt not_active IP Right Cessation
- 2000-10-06 DE DE60010914T patent/DE60010914T2/de not_active Expired - Fee Related
- 2000-10-10 CO CO00077030A patent/CO5271692A1/es not_active Application Discontinuation
- 2000-10-10 SV SV2000000191A patent/SV2002000191A/es unknown
- 2000-10-10 TN TNTNSN00196A patent/TNSN00196A1/fr unknown

Also Published As

Publication number	Publication date
AU7441100A (en)	2001-04-23
PT1220855E (pt)	2004-08-31
SV2002000191A (es)	2002-01-23
ES2219395T3 (es)	2004-12-01
PE20010674A1 (es)	2001-06-27
BR0014656A (pt)	2002-06-11
DK1220855T3 (da)	2004-09-27
WO2001027101A2 (en)	2001-04-19
DE60010914D1 (de)	2004-06-24
CO5271692A1 (es)	2003-04-30
PA8503701A1 (es)	2001-10-10
GB9923968D0 (en)	1999-12-15
EP1220855B1 (de)	2004-05-19
CA2382937A1 (en)	2001-04-19
EP1220855A2 (de)	2002-07-10
WO2001027101A3 (en)	2001-06-14
TNSN00196A1 (fr)	2005-11-10
JP2003511446A (ja)	2003-03-25
DE60010914T2 (de)	2004-10-28

Legal Events

Date

Code

Title

Description

2005-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1220855

Country of ref document: EP

2006-07-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
YU6303A (sh)	2006-03-03	Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa
MXPA03011039A (es)	2004-03-19	Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
WO1999064409A3 (de)	2000-03-02	Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE60204452D1 (de)	2005-07-07	Pyrazolo[1,5]pyridinderivate
IL185611A0 (en)	2008-01-06	Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
MY120842A (en)	2005-11-30	1,4-benzothiazepine-1, 1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use.
SE9904505D0 (sv)	1999-12-09	Novel compounds
JO2353B1 (en)	2006-12-12	New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
DE60305113D1 (de)	2006-06-14	Borsäuresalze und deren Verwendung in der Bereitstellung von Medikamente für die Thrombosebehandlung
ATE300541T1 (de)	2005-08-15	Pyrazolopyridinderivate
MY114944A (en)	2003-02-28	Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use
CA2298461A1 (en)	1999-03-04	Heterocyclic substituted 4-benzoyl-pyrazole as herbicides
MXPA04005484A (es)	2004-12-06	Procedimiento de preparacion de derivados de equinocandina.
ATE267203T1 (de)	2004-06-15	Wasserfreie salze
MXPA02004441A (es)	2004-09-10	Derivados de isoxazol como inhibidores de la fosfodiesterasa.
SE0102057D0 (sv)	2001-06-08	New Salts I
DK0457090T3 (da)	1996-04-15	Fremgangsmåde til fremstilling af 3-amino-2-(het)-aroyl-acrylsyrederivater
MY113529A (en)	2002-03-30	New derivatives of imidazole n- benzyldioxole,processes for their preparation, their use as medicaments and pharmaceutical compositions containing them
WO2001004112A3 (de)	2001-08-02	Benzofuranderivate
IL85640A0 (en)	1988-08-31	1-(1-aryl-2-hydroxyethyl)-imidazoles and salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them
WO2003013530A3 (de)	2003-09-25	Salze substituierter 1,2,3,4,-tetrahydrochinolin-2-carbonsaurederivate als nmda-antagonisten
SE9803280D0 (sv)	1998-09-25	Novel compounds
SE9803277D0 (sv)	1998-09-25	Novel compounds
PL355763A1 (en)	2004-05-17	Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same
UY26382A1 (es)	2001-05-31	Agentes terapéuticos